𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FAS/FAS ligand expression and induction of apoptosis in chondrocytes

✍ Scribed by Sanshiro Hashimoto; Morteza Setareh; Robert L. Ochs; Martin Lotz


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
795 KB
Volume
40
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Objective. To examine the expression of FasIFas ligand and the role of this ligand/receptor interaction in the regulation of apoptosis in normal human articular chondrocytes and in osteoarthritis (OA) cartilage.

Methods. Normal and OA human knee cartilage and cells isolated from these tissues were tested for Fas expression by flow cytometry. Induction of apoptosis by antibody to Fas was analyzed by DAPI staining and electron microscopy.

Results. Treatment of freshly isolated normal human articular chondrocytes with an agonistic Fas antibody induced apoptosis in a subpopulation (-20%) of the cells. Apoptosis induced by anti-Fas was not dependent on nitric oxide (NO), and anti-Fas also did not induce NO production. Analysis of isolated cells demonstrated similar levels of Fas expression on normal and OA chondrocytes (28% and 32%, respectively). In normal articular cartilage, Fas-positive cells were located mainly in the superficial and midzones. In contrast, in fibrillated OA cartilage, surface layers were partially absent and Fas-expressing cells were also detected in the deeper layers. Fas ligand messenger RNA was not detectable in resting or activated normal or OA chondrocytes. Analysis by electron microscopy showed the nuclear and cytoplasmic changes typical of apoptosis in cultures treated with antibody to Fas.

Conclusion.

A subpopulation of chondrocytes expresses Fas and is susceptible to Fas-induced apoptosis. Fas-mediated chondrocyte apoptosis may contribute to cartilage degradation in arthritis.


πŸ“œ SIMILAR VOLUMES


Fas/Fas ligand system and apoptosis indu
✍ Hans U. Schmelz; Michael Abend; Klaus Kraft; Ekkehard W. Hauck; Wolfgang Weidner πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Tumor‐infiltrating, Fas ligand (FasL)‐expressing lymphocytes are able to eliminate Fas‐bearing tumor cells by apoptosis induction. Activated cytotoxic T‐cells that express Fas may enter apoptosis in the presence of FasL tumor cells. To date, no studies of patients with te

Fas and Fas ligand-mediated apoptosis an
✍ Signore, Alberto ;Annovazzi, Alessio ;Gradini, Roberto ;Liddi, Roberto ;Ruberti, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 1 views

The relationship between Fas-mediated apoptosis and Type 1 diabetes is currently under investigation. Fas/Fas ligand interaction could be involved both in the insulitis process and in beta-cell death. Nevertheless, different mechanisms appear to be involved in human Type 1 diabetes and in NOD mice.

Expression of Fas and Fas ligand in cuta
✍ Zoi-Toli, Ourania; Meijer, Chris J. L. M.; Oudejans, Joost J.; de Vries, Els; va πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 3 views

Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i

Expression of Fas ligand in retinoblasto
✍ Subramanian Krishnakumar; Mallikarjuna Kandalam; Adithi Mohan; Anita Iyer; Nalin πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 195 KB
Expression of Fas ligand in human hepato
✍ Eui-Cheol Shin; Jeon-Soo Shin; Jeon-Han Park; Hoguen Kim; Se-Jong Kim πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 136 KB πŸ‘ 3 views

It has been postulated that tumor cells expressing Fas ligand (FasL) can evade immune surveillance by inducing apoptosis in T cells expressing Fas. In this study, we investigated FasL expression in 13 human hepatoma cell lines. Strong FasL expression was detected by reverse transcriptionpolymerase c